Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David R Plas

Showing results (41-50 of 63) with videos related to

Pageof 7
Sort By:
Cancer Research|June 3, 2004
Akt stimulates aerobic glycolysis in cancer cellsRebecca L Elstrom, Daniel E Bauer, Monica Buzzai, et al.
Molecular Cell|August 1, 2017
Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 InhibitionSang-Oh Yoon, Sejeong Shin, Florian A Karreth, et al.
The Journal of Cell Biology|May 14, 2021
Selective MAP1LC3C (LC3C) autophagy requires noncanonical regulators and the C-terminal peptideMegan E Bischoff, Yuanwei Zang, Johnson Chu, et al.
Cell Reports|March 2, 2017
Pharmacologic Targeting of S6K1 in PTEN-Deficient NeoplasiaHongqi Liu, Xizhi Feng, Kelli N Ennis, et al.
International Journal of Molecular Sciences|March 28, 2024
A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome ResistanceAniruddha S Karve, Janki M Desai, Sidharth N Gadgil, et al.
Cancer Cell|December 18, 2014
TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinomaDaniel P Hall, Nicholas G Cost, Shailaja Hegde, et al.
The Journal of Biological Chemistry|April 1, 2023
Microtubule-associated protein MAP1LC3C regulates lysosomal exocytosis and induces zinc reprogramming in renal cancer cellsRita Verma, Parul Aggarwal, Megan E Bischoff, et al.
Pharmaceuticals (Basel, Switzerland)|February 2, 2021
Reuse of Molecules for Glioblastoma TherapyAbigail Koehler, Aniruddha Karve, Pankaj Desai, et al.
Molecular Cancer Therapeutics|September 25, 2025
Preclinical Evaluation of the Efficacy of the Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination with Letrozole against Patient-Derived Glioblastoma CellsSidharth N Gadgil, Aniruddha S Karve, Gary A Gudelsky, et al.
Nature Communications|October 13, 2015
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growthSubrahmanya D Vallabhapurapu, Sunil K Noothi, Derek A Pullum, et al.
Pageof 7

Showing results (41-50 of 63) with videos related to

Sort By:
Pageof 7
Cancer Research|June 3, 2004
Akt stimulates aerobic glycolysis in cancer cellsRebecca L Elstrom, Daniel E Bauer, Monica Buzzai, et al.
Molecular Cell|August 1, 2017
Focal Adhesion- and IGF1R-Dependent Survival and Migratory Pathways Mediate Tumor Resistance to mTORC1/2 InhibitionSang-Oh Yoon, Sejeong Shin, Florian A Karreth, et al.
The Journal of Cell Biology|May 14, 2021
Selective MAP1LC3C (LC3C) autophagy requires noncanonical regulators and the C-terminal peptideMegan E Bischoff, Yuanwei Zang, Johnson Chu, et al.
Cell Reports|March 2, 2017
Pharmacologic Targeting of S6K1 in PTEN-Deficient NeoplasiaHongqi Liu, Xizhi Feng, Kelli N Ennis, et al.
International Journal of Molecular Sciences|March 28, 2024
A Review of Approaches to Potentiate the Activity of Temozolomide against Glioblastoma to Overcome ResistanceAniruddha S Karve, Janki M Desai, Sidharth N Gadgil, et al.
Cancer Cell|December 18, 2014
TRPM3 and miR-204 establish a regulatory circuit that controls oncogenic autophagy in clear cell renal cell carcinomaDaniel P Hall, Nicholas G Cost, Shailaja Hegde, et al.
The Journal of Biological Chemistry|April 1, 2023
Microtubule-associated protein MAP1LC3C regulates lysosomal exocytosis and induces zinc reprogramming in renal cancer cellsRita Verma, Parul Aggarwal, Megan E Bischoff, et al.
Pharmaceuticals (Basel, Switzerland)|February 2, 2021
Reuse of Molecules for Glioblastoma TherapyAbigail Koehler, Aniruddha Karve, Pankaj Desai, et al.
Molecular Cancer Therapeutics|September 25, 2025
Preclinical Evaluation of the Efficacy of the Cyclin-Dependent Kinase Inhibitor Ribociclib in Combination with Letrozole against Patient-Derived Glioblastoma CellsSidharth N Gadgil, Aniruddha S Karve, Gary A Gudelsky, et al.
Nature Communications|October 13, 2015
Transcriptional repression by the HDAC4-RelB-p52 complex regulates multiple myeloma survival and growthSubrahmanya D Vallabhapurapu, Sunil K Noothi, Derek A Pullum, et al.
Pageof 7